NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 03/24/21

NeuroBo Pharmaceuticals (NRBO) perks up 6% premarket after receiving approval of an amendment to its Contingent Value Rights ((CVR)) agreement from a majority of CVR holders. The CVRs were distributed to the holders of Gemphire Therapeutics (GEMP) common stock on December 30, 2019, ...

Hall of Fame Resort & Entertainment Company (HOFV) +71% after NFT deal.Dolphin Entertainment (DLPN) +66% after NFT deal.Alithya Group (ALYA) +52% on acquisition of R3D ConseilColor Star Technology (CSCW) +41%.Aptose Biosciences (APTO) +39% on Q4 results.Cinedigm C...

NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene Gemcabene to be Studied as a Stand-alone Treatment for COVID-19 and in Combination with Lead Asset, ANA001 PR Newswire BOSTON , March 24, 2021 /PRNewswire/ -- N...

NeuroBo Pharmaceuticals to Participate in H.C. Wainwright Global Life Sciences Conference PR Newswire BOSTON , March 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that Company...

NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement PR Newswire BOSTON , Jan. 21, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the closing of its previously announced pri...

Gainers: Aclaris Therapeutics (ACRS) +184%.Gritstone Oncology (GRTS) +111%.Gevo (GEVO) +76%.Senseonics (SENS) +72%.TransEnterix (TRXC) +62%.Dare Bioscience (DARE) +57%.ENDRA Life Sciences (NDRA) +41%.Pennsylvania Real Estate Investment Trust (PEI) +41%.Tenax Therapeutics (TENX)...

NeuroBo Pharmaceuticals (NRBO) to raise $10M through the private placement of 2.5M common shares and warrants to purchase up to 2.5M shares at $4/share.Closing date is January 21. The five and one-half years warrants have an exercise price of $6.03/share/ Net proceeds will be used for working...

NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement PR Newswire BOSTON , Jan. 19, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that it has entered into securities purc...

Gainers: Future FinTech (FTFT) +152%.3D Systems (DDD) +103%.Xunlei (XNET) +69%.SOS Limited (SOS) +65%.Mercurity Fintech (MFH) +44%.ZW Data Action Technologies (CNET) +42%.ENGlobal (ENG) +41%.Marathon Patent (MARA) +40%.Oragenics (OGEN) +39%.ReneSola (SOL) +34%.Losers: ...

NeuroBo Pharmaceuticals (NRBO) has acquired ANA Therapeutics, a biotechnology company developing ANA-001, currently in Phase 2/3 clinical trials as a treatment for COVID-19."This is an exciting and transformative acquisition for NeuroBo that expands our pipeline with a late-stage cl...